Zebra Therapeutics Limited is a virtual company developing novel therapeutic drugs to treat liver disease. Zebra Therapeutics Limited is currently developing a novel early-stage asset licensed as a potential treatment for non-alcoholic steatohepatitis (NASH).Through funding support, Zebra Therapeutics Limited plans to advance the licensed assets through in vivo proof of concept and lead optimisation, prior to initiation of preclinical, First In Man and Phase IIa/b clinical studies.